CA Stock MarketDetailed Quotes

HAVN HAVN Life Sciences Inc

Watchlist
  • 0.030
  • 0.0000.00%
15min DelayMarket Closed Apr 11 09:30 ET
442.16KMarket Cap-9P/E (TTM)

HAVN Life Sciences Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jan 31, 2023
(Q2)Oct 31, 2022
(Q1)Jul 31, 2022
(FY)Apr 30, 2022
(Q4)Apr 30, 2022
(Q3)Jan 31, 2022
(Q2)Oct 31, 2021
(Q1)Jul 31, 2021
(FY)Apr 30, 2021
(Q4)Apr 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
120.00%289.12K
77.47%-558.05K
64.42%-890.5K
24.44%-7.88M
-615.27%-1.45M
82.23%-1.45M
-53.24%-2.48M
-163.08%-2.5M
-13,793.21%-10.42M
281.36K
Net income from continuing operations
68.40%-691.54K
104.23%250.2K
-31.36%-3.9M
26.13%-22.44M
-3.34%-11.37M
83.37%-2.19M
-9.49%-5.92M
-263.54%-2.97M
-74,773.41%-30.38M
---11M
Operating gains losses
--76.58K
----
----
----
----
----
----
----
----
----
Depreciation and amortization
-99.92%105
-115.92%-23.48K
-65.16%45.58K
-87.50%575.62K
-93.94%165.27K
-88.61%132.04K
--147.5K
--130.82K
--4.6M
--2.73M
Asset impairment expenditure
-100.00%-1
----
----
--12.57M
--9.69M
--156.84K
----
----
--0
--0
Remuneration paid in stock
-84.09%59.69K
-63.38%276.26K
-123.71%-114.01K
-80.45%1.79M
-95.92%176.56K
-85.53%375.21K
-64.56%754.38K
407.77%480.81K
--9.14M
--4.32M
Other non cashItems
-30.59%31.71K
-15,647.66%-2.54M
17,324.43%2.95M
-97.53%168.97K
102.25%90.05K
-99.56%45.69K
-88.35%16.32K
-93.16%16.92K
1,246,394.53%6.83M
---4M
Change In working capital
2,364.13%812.57K
187.57%178.92K
183.48%133.47K
12.82%-536.2K
-105.58%-204.98K
100.72%32.98K
-125.50%-204.33K
66.40%-159.88K
-1,714.83%-615.07K
--3.67M
-Change in receivables
-14.37%220.22K
-145.94%-249.73K
186.61%55.42K
47.26%-109.07K
-321.98%-200.7K
722.06%257.17K
-39.57%-101.54K
-41.78%-64K
---206.79K
---47.56K
-Change in prepaid assets
114.29%19.17K
262.27%233.78K
808.89%72.03K
59.54%-372.21K
-102.02%-83.81K
97.18%-134.17K
-137.21%-144.07K
98.54%-10.16K
-1,126.63%-919.97K
--4.15M
-Change in payables and accrued expense
736.74%573.18K
372.11%194.87K
107.02%6.02K
-110.73%-54.93K
118.57%79.53K
-147.42%-90.02K
-91.52%41.28K
-132.58%-85.72K
1,144.72%511.69K
---428.22K
Cash from discontinued investing activities
Operating cash flow
120.00%289.12K
77.47%-558.05K
64.42%-890.5K
24.44%-7.88M
66.12%-1.45M
59.57%-1.45M
-53.24%-2.48M
-163.08%-2.5M
-13,793.21%-10.42M
---4.28M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
-411.91%-2.03M
122.13%28K
-208.29%-16.96K
-4,281.31%-956.4K
-346.93%-1.09M
-58.68%-396.7K
-126.51K
Net PPE purchase and sale
--0
--0
--0
-130.20%-75.07K
185.86%28K
---16.96K
---729
---85.39K
---32.61K
---32.61K
Net business purchase and sale
--0
--0
--0
-246.76%-1.2M
--0
--0
-64.16%-200K
-600.00%-1M
---346.06K
---81.37K
Net other investing changes
----
----
----
-4,091.17%-755.67K
--0
--0
----
----
92.79%-18.03K
---12.53K
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
-411.91%-2.03M
122.13%28K
-208.29%-16.96K
-4,281.31%-956.4K
-346.93%-1.09M
-58.68%-396.7K
---126.51K
Financing cash flow
Cash flow from continuing financing activities
-766.83%-283.77K
6,304.86%454.26K
-61.09%-52.74K
-91.62%1.56M
250.96%1.63M
-100.22%-32.74K
-101.12%-7.32K
-101.34%-32.74K
857.95%18.6M
465.18K
Net issuance payments of debt
-766.83%-283.77K
1,487.60%454.26K
0.00%-32.74K
-300.00%-130.95K
0.00%-32.74K
---32.74K
---32.74K
---32.74K
---32.74K
---32.74K
Net common stock issuance
----
----
----
-85.85%2M
----
----
----
----
635.31%14.13M
--0
Proceeds from stock option exercised by employees
--0
----
----
-99.55%25.66K
-99.95%245
--0
----
----
--5.67M
--497.92K
Net other financing activities
--0
--0
---20K
71.23%-334.69K
----
----
----
----
-5,916.88%-1.16M
--0
Cash from discontinued financing activities
Financing cash flow
-766.83%-283.77K
6,304.86%454.26K
-61.09%-52.74K
-91.62%1.56M
250.96%1.63M
-100.22%-32.74K
-101.12%-7.32K
-101.34%-32.74K
857.95%18.6M
--465.18K
Net cash flow
Beginning cash position
-99.63%8.63K
-98.06%112.42K
-88.77%1.06M
481.43%9.4M
-93.67%844.86K
24.48%2.34M
101.93%5.78M
481.43%9.4M
--1.62M
--13.34M
Current changes in cash
100.36%5.36K
96.98%-103.79K
73.95%-943.24K
-207.21%-8.35M
105.35%210.8K
-113.05%-1.5M
-250.09%-3.44M
-390.60%-3.62M
381.46%7.78M
---3.94M
End cash Position
-98.34%13.99K
-99.63%8.63K
-98.06%112.42K
-88.77%1.06M
-88.77%1.06M
-93.67%844.86K
24.48%2.34M
101.93%5.78M
481.46%9.4M
--9.4M
Free cash from
119.77%289.12K
77.48%-558.05K
65.59%-890.5K
23.69%-7.98M
66.37%-1.45M
59.09%-1.46M
-53.29%-2.48M
-172.05%-2.59M
-13,836.69%-10.45M
---4.31M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Jan 31, 2023(Q2)Oct 31, 2022(Q1)Jul 31, 2022(FY)Apr 30, 2022(Q4)Apr 30, 2022(Q3)Jan 31, 2022(Q2)Oct 31, 2021(Q1)Jul 31, 2021(FY)Apr 30, 2021(Q4)Apr 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 120.00%289.12K77.47%-558.05K64.42%-890.5K24.44%-7.88M-615.27%-1.45M82.23%-1.45M-53.24%-2.48M-163.08%-2.5M-13,793.21%-10.42M281.36K
Net income from continuing operations 68.40%-691.54K104.23%250.2K-31.36%-3.9M26.13%-22.44M-3.34%-11.37M83.37%-2.19M-9.49%-5.92M-263.54%-2.97M-74,773.41%-30.38M---11M
Operating gains losses --76.58K------------------------------------
Depreciation and amortization -99.92%105-115.92%-23.48K-65.16%45.58K-87.50%575.62K-93.94%165.27K-88.61%132.04K--147.5K--130.82K--4.6M--2.73M
Asset impairment expenditure -100.00%-1----------12.57M--9.69M--156.84K----------0--0
Remuneration paid in stock -84.09%59.69K-63.38%276.26K-123.71%-114.01K-80.45%1.79M-95.92%176.56K-85.53%375.21K-64.56%754.38K407.77%480.81K--9.14M--4.32M
Other non cashItems -30.59%31.71K-15,647.66%-2.54M17,324.43%2.95M-97.53%168.97K102.25%90.05K-99.56%45.69K-88.35%16.32K-93.16%16.92K1,246,394.53%6.83M---4M
Change In working capital 2,364.13%812.57K187.57%178.92K183.48%133.47K12.82%-536.2K-105.58%-204.98K100.72%32.98K-125.50%-204.33K66.40%-159.88K-1,714.83%-615.07K--3.67M
-Change in receivables -14.37%220.22K-145.94%-249.73K186.61%55.42K47.26%-109.07K-321.98%-200.7K722.06%257.17K-39.57%-101.54K-41.78%-64K---206.79K---47.56K
-Change in prepaid assets 114.29%19.17K262.27%233.78K808.89%72.03K59.54%-372.21K-102.02%-83.81K97.18%-134.17K-137.21%-144.07K98.54%-10.16K-1,126.63%-919.97K--4.15M
-Change in payables and accrued expense 736.74%573.18K372.11%194.87K107.02%6.02K-110.73%-54.93K118.57%79.53K-147.42%-90.02K-91.52%41.28K-132.58%-85.72K1,144.72%511.69K---428.22K
Cash from discontinued investing activities
Operating cash flow 120.00%289.12K77.47%-558.05K64.42%-890.5K24.44%-7.88M66.12%-1.45M59.57%-1.45M-53.24%-2.48M-163.08%-2.5M-13,793.21%-10.42M---4.28M
Investing cash flow
Cash flow from continuing investing activities 000-411.91%-2.03M122.13%28K-208.29%-16.96K-4,281.31%-956.4K-346.93%-1.09M-58.68%-396.7K-126.51K
Net PPE purchase and sale --0--0--0-130.20%-75.07K185.86%28K---16.96K---729---85.39K---32.61K---32.61K
Net business purchase and sale --0--0--0-246.76%-1.2M--0--0-64.16%-200K-600.00%-1M---346.06K---81.37K
Net other investing changes -------------4,091.17%-755.67K--0--0--------92.79%-18.03K---12.53K
Cash from discontinued investing activities
Investing cash flow --0--0--0-411.91%-2.03M122.13%28K-208.29%-16.96K-4,281.31%-956.4K-346.93%-1.09M-58.68%-396.7K---126.51K
Financing cash flow
Cash flow from continuing financing activities -766.83%-283.77K6,304.86%454.26K-61.09%-52.74K-91.62%1.56M250.96%1.63M-100.22%-32.74K-101.12%-7.32K-101.34%-32.74K857.95%18.6M465.18K
Net issuance payments of debt -766.83%-283.77K1,487.60%454.26K0.00%-32.74K-300.00%-130.95K0.00%-32.74K---32.74K---32.74K---32.74K---32.74K---32.74K
Net common stock issuance -------------85.85%2M----------------635.31%14.13M--0
Proceeds from stock option exercised by employees --0---------99.55%25.66K-99.95%245--0----------5.67M--497.92K
Net other financing activities --0--0---20K71.23%-334.69K-----------------5,916.88%-1.16M--0
Cash from discontinued financing activities
Financing cash flow -766.83%-283.77K6,304.86%454.26K-61.09%-52.74K-91.62%1.56M250.96%1.63M-100.22%-32.74K-101.12%-7.32K-101.34%-32.74K857.95%18.6M--465.18K
Net cash flow
Beginning cash position -99.63%8.63K-98.06%112.42K-88.77%1.06M481.43%9.4M-93.67%844.86K24.48%2.34M101.93%5.78M481.43%9.4M--1.62M--13.34M
Current changes in cash 100.36%5.36K96.98%-103.79K73.95%-943.24K-207.21%-8.35M105.35%210.8K-113.05%-1.5M-250.09%-3.44M-390.60%-3.62M381.46%7.78M---3.94M
End cash Position -98.34%13.99K-99.63%8.63K-98.06%112.42K-88.77%1.06M-88.77%1.06M-93.67%844.86K24.48%2.34M101.93%5.78M481.46%9.4M--9.4M
Free cash from 119.77%289.12K77.48%-558.05K65.59%-890.5K23.69%-7.98M66.37%-1.45M59.09%-1.46M-53.29%-2.48M-172.05%-2.59M-13,836.69%-10.45M---4.31M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg